TipRanks
Amgen (IT:1AMGN)
:1AMGN
Italy Market

Amgen (1AMGN) Drug Pipeline

2 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Semaglutide, Maridebart Cafraglutide, Amg 133
Diabetes Mellitus, Type 2
Phase III
Not Yet Recruiting
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Oct 05, 2026
Romosozumab
Healthy Participants
Phase I
Recruiting
Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC Injections
Sep 04, 2026
―
Autoinjector, Evolocumab, Routine Lipid Management
Hypercholesterolemia, Coronary Artery Disease, Atheroma, Atherosclerotic Plaque
Phase IV
Not Yet Recruiting
A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma
Aug 31, 2026
Tarlatamab, Imdelltra
Small Cell Lung Cancer
Phase III
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Aug 12, 2026
Amg 691
Healthy Participants
Phase I
Recruiting
A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
Jul 30, 2026
Romiplostim, Predniso Ne
Primary Immune Thrombocytopenia
Phase III
Recruiting
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Jul 07, 2026
Maridebart Cafraglutide, Amg 133
Obesity, Overweight
Phase III
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Jun 29, 2026
Maridebart Cafraglutide, Amg 133
Obesity, Overweight, Diabetes Mellitus, Type 2
Phase III
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Jun 29, 2026
Aflibercept 8 Mg, Abp 938 8 Mg, Eylea Hd
Neovascular Age-Related Macular Degeneration, Namd
Phase III
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
May 22, 2026
Standard Of Care, Inebilizumab
Autoimmune Hepatitis, Aih
Phase III
Not Yet Recruiting
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
May 14, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Amgen (1AMGN) have in its pipeline
      1AMGN is currently developing the following drugs: Semaglutide, Maridebart Cafraglutide, Amg 133, Romosozumab, Autoinjector, Evolocumab, Routine Lipid Management. These drug candidates are in various stages of clinical development as the company works toward FDA approval.